Total and Fetal Circulating Cell-Free DNA, Angiogenic, and Antiangiogenic Factors in Preeclampsia and HELLP Syndrome | Zendy

Rocío MúñozHernández | Zendy; Pablo MedranoCampillo | Zendy; María Luisa Miranda | Zendy; Hada C. Macher | Zendy; Juan Manuel PraenaFernández | Zendy; Antonio J. VallejoVaz | Zendy; María J. Dominguez-Simeon | Zendy; Rafael MorenoLuna | Zendy; Pablo Stiefel | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Total and Fetal Circulating Cell-Free DNA, Angiogenic, and Antiangiogenic Factors in Preeclampsia and HELLP Syndrome

Author(s) -

Rocío MúñozHernández,

Pablo MedranoCampillo,

María Luisa Miranda,

Hada C. Macher,

Juan Manuel PraenaFernández,

Antonio J. VallejoVaz,

María J. Dominguez-Simeon,

Rafael MorenoLuna,

Pablo Stiefel

Publication year - 2017

Publication title -

american journal of hypertension

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.009

H-Index - 136

eISSN - 1941-7225

pISSN - 0895-7061

DOI - 10.1093/ajh/hpx024

Subject(s) - hellp syndrome , medicine , preeclampsia , placental growth factor , proteinuria , endoglin , gastroenterology , receiver operating characteristic , cell free fetal dna , soluble fms like tyrosine kinase 1 , fetus , pregnancy , endocrinology , vascular endothelial growth factor , prenatal diagnosis , genetics , stem cell , cd34 , vegf receptors , biology , kidney

Preeclampsia (PE) is a hypertensive disorder of pregnancy characterized by hypertension and proteinuria. The HELLP syndrome is the most severe form of PE. The aim of the present study was to determine different potential biomarkers that may help us perform an early diagnosis of the disease, assess on the severity of the disease, and/or predict maternal or fetal adverse outcomes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research